ResearchMOZ
Pharmaceutical Industry in China Q3 2013 | Industry Shares, Size, Trend, Analysis, and Forecasts Report Available Online by Researchmoz.us
Albany, NewYork (PRWEB) December 07, 2013
This report tackles not only global pharmaceutical company interest in China but also home grown companies and their battle for position. The business environment in which they compete is analysed as are key drivers, constraints, challenges and opportunities.
The Chinese Pharmaceutical market is currently the third greatest pharma market globally, after the US and Japan, and in 2011 was worth $x. It is forecast to increase dramatically to $x by 2015 and increase its dominance as a leading player in Asia. As the current third market leader it is predicted that the Chinese pharma market will be the main competitor of the US by 2020.
Click Here To Read Full Report With TOC @ http://www.researchmoz.us/pharmaceutical-industry-in-china-q3-2013-cutting-edge-analysis-of-multinational-and-chinese-pharma-companies-industry-trends-environment-regulation-market-drivers-restraints-opportunities-and-challenges-report.html
This report describes the current therapeutics that are propelling the biopharmaceutical market in China. It examines the current economic climate and how China compares to other emerging markets and also evolved markets such as the US and Europe. Current developments relating to patent expirations, government funding, and regulations are discussed. The emerging trends that appear in key sub-markets such as generics, oncology, diabetes and vaccines are elucidated and analysed.
This study reveals market figures of the overall Chinese pharmaceutical market and sub-markets. Forecast projections and future growth rates are provided to give the reader a forthcoming perspective of this growing industry. The study also provides a comprehensive financial and product review of key players in the biopharmaceutical industry in China. Strategic drivers and restraints of this market are revealed and market opportunities and challenges are identified.
In summary, the Chinese biopharmaceutical market has huge opportunities for growth. This industry will significantly affect the international healthcare market and has enormous potential for investment.
Pharmaceutical Industry China Q3 2013 – Cutting-Edge Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges” provides you with a detailed investigation of the market size, segmentation, key players, SWOT analysis, influential Government policies, and business and economic environments. The report is supported by over 196 tables & figures within 145 pages. The Chinese biopharmaceutical market is presented as follows:
By Company (e.g., AMOYTOP BIOTECH, BEIJING CONTINENT PHARMACEUTICALS, FUSOGEN, SHANGHAI HUAGUAN BIOCHIP, SIBIONO GENETECH, ABBOTT, ROCHE, PFIZER, GSK, NOVARTIS)
By Therapeutic Area (e.g., Anti-infective, Cancer, Diabetes, Dementia, Depression)
Browse All Pharmaceutical Market Research Report @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html
A wealth of financial information is provided including:
Company financials, sales & revenue figures – historical to Q2•2013
China GDP, economic growth, export (bulk drug, formulations) figures
Indian health expenditure as a function of GDP
Growth change figures of emerging and developing countries (India, Russia, China, Brazil)
Economic growth figures of advanced economies (USA, UK, Germany, France, Italy, Spain, Japan, Canada)
Projected figures of strategic emerging industry GDP percentage contribution
SWOT, Economic and Business Environment specifics include:
Key strengths, weaknesses and threats influencing leading player position within the market
Top Five Contract Pharmaceutical Export Markets of China
Major players within China’s leading therapeutic markets (e.g., cancer, allergy, liver disease)
Multinational penetration into the Chinese Pharma Market
Comprehensive product portfolios, R&D activity and pipeline therapeutics
M&A activity and future strategies of top Chinese pharmacos
Economic indicators, trade policy, merchandise and commercial trade statistics
Gross Domestic Product of China, historic and projection analysis
Chinese economic outlook in comparison to advanced economies
Three Tier ‘Pharmerging’ Markets with Potential for Significant Growth
Prescription drug sales distribution channels in China
Major biogeneric products in China
This report highlights a number of significant Chinese and multinational pharmacos and gives details of their operations, products, financials and business strategy.
All Latest Market Research Report @ http://www.researchmoz.us/latest-report.html
Amoytop Biotech
Active Pharmaceutical Products
Beijing Continent Pharmaceuticals
FusoGen Pharmaceuticals
Shanghai Huaguan Biochip
SiBiono GeneTech
Abbott
AstraZeneca
Boehringer Ingelheim
Eli Lilly
GlaxoSmithKline
Johnson & Johnson Medical
Merck
Novartis
Pfizer
Roche
Forecast projections and future growth rates are provided to give you a forthcoming perspective of this growing industry. Current developments relating to patent expirations, government funding, and regulations are discussed. The emerging trends that appear in key sub-markets such as generics, oncology, cardiovascular, diabetes and vaccines are elucidated and analysed.
What you will gain:
An in-depth understanding of the Chinese biopharmaceutical market and it’s environment
Current market facts, figures and product lines of key players in the industry
An insight into how generic therapeutics will propagate the Chinese biopharmaceutical market
Knowledge of how the Chinese pharma market will integrate into the global healthcare market
Information on key regulatory and government policies
Data on levels of private and publically funded biopharma studies in China
Strategies on how to adapt and restructure current business models to this industry
Read All Kelly Scientific Publications Market Research Reports @ http://www.researchmoz.us/publisher/kelly-scientific-publications-96.html
This report tackles key concerns to the Chinese biopharmaceutical market such as:
Lack of regulatory policy and legislation
Reimbursement schemes and payers concerns
Funding and government sponsorship issues
International scepticism of Chinese safety and efficacy therapeutic profiles
This report will tell you if the companies mentioned are:
Strong, competitive players
Pooling their resources for specific growth and therapeutic areas
Investing strategically in R&D
Have a history of strategic M&A activity
Related Report
Antibiotics Partnering Terms and Agreements
The Antibiotics Partnering Terms and Agreements (http://www.researchmoz.us/antibiotics-partnering-terms-and-agreements-report.html)report provides an understanding and access to the antibiotics partnering deals and agreements entered into by the worlds leading healthcare companies.The report provides a detailed understanding and analysis of how and why companies enter antibiotics partnering deals. The majority of deals are early development stage whereby the licensee obtains a right or an option right to license the licensors antibiotics technology or product candidates. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
China Large Volume Parenteral Market
Overcapacity and fierce(http://www.researchmoz.us/china-large-volume-parenteral-lvp-industry-report-2013-2015-report.html) competition are caused by the irrational injection product structure and homogeneity. For example, the output and sales volume of fluid balance injection products with low added value account for 89% of the injection market, but the sales revenue only shares 47%. At the same time, the market demand for amino acids, fat emulsion dual-chamber bags, fat emulsion, total parenteral nutrition, hydroxyethyl starch and unique traditional Chinese medicine injection is quite strong.
About Us
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Email: sales(at)researchmoz(dot)us
http://www.researchmoz.us/
Blog: http://industryresearchnews.blogspot.com